Skin Barrier Formation Pathways

Skin barrier formation pathways encompass the complex molecular and cellular processes responsible for establishing and maintaining the skin's protective permeability barrier, primarily located in the stratum corneum. This process involves the terminal differentiation of keratinocytes into anucleated corneocytes, which are cross-linked by proteins such as filaggrin, loricrin, and involucrin to form a resilient cornified envelope [3, 8, 20]. These bricks are embedded in a mortar of lipid lamellae composed of ceramides, cholesterol, and free fatty acids, which prevent excessive transepidermal water loss and protect against environmental insults [4, 16, 21]. Key signaling axes, including the CARD14-NFκB and RIPK4-Hippo pathways, regulate the expression of genes essential for this structural integrity and the skin's antimicrobial defense [2, 8, 11]. Dysfunction in these pathways is a hallmark of inflammatory skin diseases such as atopic dermatitis and psoriasis, where genetic mutations (e.g., in the FLG gene) or cytokine-driven inflammation disrupt barrier homeostasis [3, 14, 20]. Therapeutic strategies targeting these pathways include the use of emollients to replenish lipids, as well as biologics and small molecules that inhibit pro-inflammatory cytokines (e.g., IL-4, IL-13, IL-17) or signaling enzymes (e.g., JAKs) to restore barrier function and alleviate symptoms [3, 10, 14]. Additionally, targeted cancer therapies like EGFR inhibitors can inadvertently disrupt these pathways, leading to significant cutaneous toxicities [10].

Other names

Epidermal barrier formation pathwaysStratum corneum formation pathwaysKeratinocyte differentiation pathwaysSkin permeability barrier pathways

Modulation of keratinocyte differentiation, lipid synthesis, and inflammatory cytokine signaling to restore or maintain the epidermal permeability barrier.